Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China

Bibliographic Details
Main Authors: Kun-Peng Li, Jing-Yu Jin, Jin-Shui Yang, Yan Li, Wei Zhao, Gui Luo, Jian Zhu, Jiang-Lin Zhang, Feng Huang
Format: Article
Language:English
Published: Termedia Publishing House 2018-06-01
Series:Archives of Medical Science
Subjects:
Online Access:https://www.termedia.pl/Full-dose-half-dose-or-discontinuation-of-etanercept-biosimilar-in-early-axial-spondyloarthritis-patients-a-real-world-study-in-China,19,32912,1,1.html
_version_ 1811225825250377728
author Kun-Peng Li
Jing-Yu Jin
Jin-Shui Yang
Yan Li
Wei Zhao
Gui Luo
Jian Zhu
Jiang-Lin Zhang
Feng Huang
author_facet Kun-Peng Li
Jing-Yu Jin
Jin-Shui Yang
Yan Li
Wei Zhao
Gui Luo
Jian Zhu
Jiang-Lin Zhang
Feng Huang
author_sort Kun-Peng Li
collection DOAJ
first_indexed 2024-04-12T09:13:42Z
format Article
id doaj.art-61dac784254a4f798d95e75258c703a0
institution Directory Open Access Journal
issn 1734-1922
1896-9151
language English
last_indexed 2024-04-12T09:13:42Z
publishDate 2018-06-01
publisher Termedia Publishing House
record_format Article
series Archives of Medical Science
spelling doaj.art-61dac784254a4f798d95e75258c703a02022-12-22T03:38:53ZengTermedia Publishing HouseArchives of Medical Science1734-19221896-91512018-06-0115370070510.5114/aoms.2018.7614132912Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in ChinaKun-Peng LiJing-Yu JinJin-Shui YangYan LiWei ZhaoGui LuoJian ZhuJiang-Lin ZhangFeng Huanghttps://www.termedia.pl/Full-dose-half-dose-or-discontinuation-of-etanercept-biosimilar-in-early-axial-spondyloarthritis-patients-a-real-world-study-in-China,19,32912,1,1.htmlaxial spondyloarthritis tnf blockers etanercept biosimilar dose reduction remission
spellingShingle Kun-Peng Li
Jing-Yu Jin
Jin-Shui Yang
Yan Li
Wei Zhao
Gui Luo
Jian Zhu
Jiang-Lin Zhang
Feng Huang
Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China
Archives of Medical Science
axial spondyloarthritis
tnf blockers
etanercept biosimilar
dose reduction
remission
title Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China
title_full Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China
title_fullStr Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China
title_full_unstemmed Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China
title_short Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China
title_sort full dose half dose or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients a real world study in china
topic axial spondyloarthritis
tnf blockers
etanercept biosimilar
dose reduction
remission
url https://www.termedia.pl/Full-dose-half-dose-or-discontinuation-of-etanercept-biosimilar-in-early-axial-spondyloarthritis-patients-a-real-world-study-in-China,19,32912,1,1.html
work_keys_str_mv AT kunpengli fulldosehalfdoseordiscontinuationofetanerceptbiosimilarinearlyaxialspondyloarthritispatientsarealworldstudyinchina
AT jingyujin fulldosehalfdoseordiscontinuationofetanerceptbiosimilarinearlyaxialspondyloarthritispatientsarealworldstudyinchina
AT jinshuiyang fulldosehalfdoseordiscontinuationofetanerceptbiosimilarinearlyaxialspondyloarthritispatientsarealworldstudyinchina
AT yanli fulldosehalfdoseordiscontinuationofetanerceptbiosimilarinearlyaxialspondyloarthritispatientsarealworldstudyinchina
AT weizhao fulldosehalfdoseordiscontinuationofetanerceptbiosimilarinearlyaxialspondyloarthritispatientsarealworldstudyinchina
AT guiluo fulldosehalfdoseordiscontinuationofetanerceptbiosimilarinearlyaxialspondyloarthritispatientsarealworldstudyinchina
AT jianzhu fulldosehalfdoseordiscontinuationofetanerceptbiosimilarinearlyaxialspondyloarthritispatientsarealworldstudyinchina
AT jianglinzhang fulldosehalfdoseordiscontinuationofetanerceptbiosimilarinearlyaxialspondyloarthritispatientsarealworldstudyinchina
AT fenghuang fulldosehalfdoseordiscontinuationofetanerceptbiosimilarinearlyaxialspondyloarthritispatientsarealworldstudyinchina